1-3 of 3
Peter Mueller, MD
Close
Sort by
Journal Articles

Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation with Venetoclax, Hypomethylating Agents and DLI - a Retrospective Multi Center Study

Esther Schuler, MD, Eva-Maria Wagner-Drouet, MD, Salem Ajib, MD, Gesine Bug, Martina Crysandt, MD, Sabine Dressler, MD, Andreas Hausmann, MD, Daniela Heidenreich, MD, Klaus Hirschbühl, MD, Matthias Hoepting, MD, Edgar Jost, MD, Jennifer Kaivers, MD, Stefan A Klein, MD, Lambros Kordelas, MD, Oliver Kriege, MD, Lutz Peter Mueller, MD, Christina Rautenberg, MD, Judith Schaffrath, MD, Christoph Schmid, MD, Daniel Wolff, MD, Martin Bornhaeuser, MD, Thomas Schroeder, MD, Guido Kobbe, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4563.
https://doi.org/10.1182/blood-2019-125087
Published: 2019
Journal Articles

Marked Improvement of Skin Involvement in Severe Progressive Systemic Sclerosis after Transplantation of Mesenchymal Stem Cells from an Allogeneic Haploidentical Related Donor.

Maximilian Christopeit, MD, Marit Schendel, MD, Lutz Peter Mueller, MD, Gernot Keyszer, MD, Gerhard Behre, MD
Journal: Blood
Blood (2007) 110 (11): 4865.
https://doi.org/10.1182/blood.V110.11.4865.4865
Published: 2007
Journal Articles

Single High-Dose Chemoradiotherapy Versus Tandem High Dose Melphalan Followed by Auto-SCT for Advanced Multiple Myeloma. Preliminary Analysissis.

Hermann Einsele, MD, Peter Liebisch, MD, Ralf Bargou, MD, Christoph Meisner, Bernd Metzner, MD, Hannes Wandt, MD, Hans-Heinrich Wolf, MD, Orhan Sezer, MD, Jochen Casper, MD, Michael Pfreundschuh, MD, Georg Maschmeyer, MD, Christian Straka, MD, Lothar Truemper, MD, Nikolaus Kroeger, MD, Peter Mueller, MD, Bernd Hertenstein, MD, Nikolaus Frickhofen, MD, Paolo Coser, MD, Michael Bamberg, MD, Holger Hebart, MD, Lothar Kanz, MD
Journal: Blood
Blood (2004) 104 (11): 537.
https://doi.org/10.1182/blood.V104.11.537.537
Published: 2004